149 related articles for article (PubMed ID: 36351338)
1. Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
Montes de Oca MK; Wilson LE; Previs RA; Gupta A; Joshi A; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
J Natl Compr Canc Netw; 2022 Nov; 20(11):1255-1266.e11. PubMed ID: 36351338
[TBL] [Abstract][Full Text] [Related]
2. Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian Cancer.
Akinyemiju TF; Wilson LE; Diaz N; Gupta A; Huang B; Pisu M; Deveaux A; Liang M; Previs RA; Moss HA; Joshi A; Ward KC; Schymura MJ; Berchuck A; Potosky AL
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1383-1393. PubMed ID: 35477150
[TBL] [Abstract][Full Text] [Related]
3. Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD study.
Montes de Oca MK; Chen Q; Howell E; Wilson LE; Meernik C; Previs RA; Huang B; Pisu M; Liang MI; Ward KC; Schymura MJ; Berchuck A; Akinyemiju T
JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36794910
[TBL] [Abstract][Full Text] [Related]
4. Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation.
Gupta A; Chen Q; Wilson LE; Huang B; Pisu M; Liang M; Previs RA; Moss HA; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
JAMA Netw Open; 2023 Feb; 6(2):e2254595. PubMed ID: 36723938
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancer.
Akinyemiju T; Deveaux A; Wilson L; Gupta A; Joshi A; Bevel M; Omeogu C; Ohamadike O; Huang B; Pisu M; Liang M; McFatrich M; Daniell E; Fish LJ; Ward K; Schymura M; Berchuck A; Potosky AL
BMJ Open; 2021 Oct; 11(10):e052808. PubMed ID: 34607872
[TBL] [Abstract][Full Text] [Related]
6. Healthcare Access Domains Mediate Racial Disparities in Ovarian Cancer Treatment Quality in a US Patient Cohort: A Structural Equation Modelling Analysis.
Akinyemiju T; Chen Q; Wilson LE; Previs RA; Joshi A; Liang M; Pisu M; Ward KC; Berchuck A; Schymura MJ; Huang B
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):74-81. PubMed ID: 36306380
[TBL] [Abstract][Full Text] [Related]
7. Health Care Access Dimensions and Racial Disparities in End-of-Life Care Quality among Patients with Ovarian Cancer.
Karanth S; Osazuwa-Peters OL; Wilson LE; Previs RA; Rahman F; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
Cancer Res Commun; 2024 Mar; 4(3):811-821. PubMed ID: 38441644
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
[TBL] [Abstract][Full Text] [Related]
9. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
10. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
Chen F; Bailey CE; Alvarez RD; Shu XO; Zheng W
Gynecol Oncol; 2021 Jan; 160(1):10-15. PubMed ID: 33208254
[TBL] [Abstract][Full Text] [Related]
11. Racial and socioeconomic disparities in survival among women with advanced-stage ovarian cancer who received systemic therapy.
Washington CJ; Karanth SD; Wheeler M; Aduse-Poku L; Braithwaite D; Akinyemiju TF
Cancer Causes Control; 2024 Mar; 35(3):487-496. PubMed ID: 37874478
[TBL] [Abstract][Full Text] [Related]
12. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
13. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025
[No Abstract] [Full Text] [Related]
14. Healthcare access dimensions and uterine cancer survival: a national cancer database study.
Anastasio MK; Gupta A; Akinyemiju TF; Previs RA
Front Oncol; 2023; 13():1263371. PubMed ID: 37869101
[TBL] [Abstract][Full Text] [Related]
15. Disparities in treatment and survival among elderly ovarian cancer patients.
Taylor JS; He W; Harrison R; Zhao H; Sun CC; Lu KH; Giordano SH; Meyer LA
Gynecol Oncol; 2018 Nov; 151(2):269-274. PubMed ID: 30253875
[TBL] [Abstract][Full Text] [Related]
16. Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer in the United States.
Nogueira LM; May FP; Yabroff KR; Siegel RL
J Clin Oncol; 2024 Apr; 42(12):1368-1377. PubMed ID: 37939323
[TBL] [Abstract][Full Text] [Related]
17. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
[TBL] [Abstract][Full Text] [Related]
19. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.
Terplan M; Schluterman N; McNamara EJ; Tracy JK; Temkin SM
Gynecol Oncol; 2012 Apr; 125(1):19-24. PubMed ID: 22108636
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in the Receipt of Guideline Care and Cancer Deaths for Women with Ovarian Cancer.
Cronin KA; Howlader N; Stevens JL; Trimble EL; Harlan LC; Warren JL
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):539-545. PubMed ID: 30487136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
